Kerendia

Medicinal product

(Invented) name

Kerendia

Active substance (s)

Finerenonas

Strength

40 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA05, finerenone

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2022-02-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Finerenonas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120394	106498	1106498	lizdinė plokštelė	N14		Receptinis	EU/1/21/1616/011	Netiekiama	-	-	No	-	-
120395	106499	1106499	lizdinė plokštelė	N28		Receptinis	EU/1/21/1616/012	Netiekiama	-	-	No	-	-
120396	106500	1106500	lizdinė plokštelė	N98		Receptinis	EU/1/21/1616/013	Netiekiama	-	-	No	-	-
120397	106501	1106501	dalomoji lizdinė plokštelė	N100×1		Receptinis	EU/1/21/1616/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-16	Registruotas